MCM
SMTI icon

MAI Capital Management’s Sanara MedTech SMTI Stock Holding History

MAI Capital Management’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12
Closed -$207 – 4336
2026
Q1 		$207 Buy
12
+11
+1,100% +$226 ﹤0.01% 4613
2025
Q4 		$24 Buy
+1
New +$26 ﹤0.01% 4303

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 8.37% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

MAI Capital Management's SMTI Position: Q2 2026 in Review

MAI Capital Management sold out of Sanara MedTech (SMTI) in Q2 2026, closing a stake of 12 shares — an estimated $207 sold.

MAI Capital Management first reported a position in SMTI in Q4 2025 and held it in 2 quarters. The position peaked at $207 in Q1 2026. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • MAI Capital Management reported no remaining Sanara MedTech position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 12 Sanara MedTech shares in Q2 2026, an estimated $207.
  • MAI Capital Management first reported a position in Sanara MedTech in Q4 2025 and held it in 2 quarters.
  • MAI Capital Management's Sanara MedTech position peaked at $207 in Q1 2026.
  • 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.